Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2024 | Story Edzani Nephalela | Photo Charl Devenish
Louzanne Coetzee
During the Faculty of Education ceremony, Louzanne Coetzee, a blind UFS alumna and speaker, shared her remarkable journey. From her days as a high school learner to becoming a student, she highlighted her challenges and how she overcame them.

The April graduations at the University of the Free State (UFS) were a remarkable celebration of diversity and inclusivity, with 44 graduates with learning difficulties, visual, mobility, or hearing impairments honoured for their achievements.

Despite facing unique challenges throughout their academic journeys, these resilient students triumphed over adversity to earn their degrees, inspiring their peers and educators alike – all with the assistance of the Centre for Universal Access and Disability Support (CUADS) within the Division of Student Affairs.

Words of advice from the recent graduates

Nkosingiphile Nyanale, who is blind, recently graduated with a Bachelor of Laws (LLB) degree. He emphasised the importance of mutual understanding between students and educators as a way of helping students with disabilities to overcome the extra hurdles they face. “One of the most challenging parts of my journey was reaching a common understanding with some facilitators on how I could be reasonably accommodated in class,” Nyanale said. “Some lecturers would deny themselves the opportunity to understand the challenges of students with visual impairments and viewed my requests as a way of seeking an easy pass. So, peers and lecturers understanding various impairments helped shape my journey.

Sthembiso Dlamini, a BSc Mathematics and Mathematical Statistics graduate who lives with dysgraphia, a condition that creates challenges related to handwriting, spelling, and organising thoughts on paper, said, “In my third year, I struggled to focus during high-stress exams. I willingly sacrificed much of my leisure time to tackle this obstacle head-on. I committed myself to honing my learning methods and enhancing my time-management abilities.” 

Relebohile Moloi, a nursing graduate, thanked CUADS for its help, and said greater awareness of the centre and its services could help more students. “They should assess students regularly for impairments, because sometimes people don’t know they have an impairment. CUADS should visit each faculty to give information on who they are and what they offer.”

The speaker

Louzanne Coetzee, a blind UFS alumna, shared her story during the last graduation session of the season on 20 April. “After matriculating at the Pioneer School in Worcester [Western Cape], where it was a protected environment, I did not know what to expect from the UFS. However, the UFS gave me a conducive environment by allowing my guide dog, Isabel, into the residences. I was the first person to be allowed such.” [Listen to her full speech here.]

Inclusive environment

Martie Miranda, Deputy Director at CUADS, said she’s proud of the graduates, as they embody the UFS’s dedication to an inclusive environment that caters to all its students, in line with the university’s Vision 130, which aims to foster academic excellence in a diverse and equitable environment. “In celebrating our graduates, we honour not just their achievements but the enduring commitment of CUADS staff and the university to foster an inclusive environment where every student's journey is valued and supported."

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept